Search
Search
David S. Boyer, MD; and Marion R. Munk, MD, PhD
Show Description +
David S. Boyer, MD, and Marion R. Munk, MD, PhD, discuss pivotal findings from the LIGHTSITE III clinical trial in patients with dry age-related macular degeneration (AMD). Dr. Boyer underscores the potential of this innovative treatment to deliver meaningful clinical benefits, emphasizing its favorable safety profile. Dr. Munk offers a comprehensive review of the study design and parameters, providing valuable context and interpretation of the trial’s outcomes. Valeda® Light Delivery System is FDA-Authorized, CE-Marked, UKCA-Marked, and commercially available in select countries across Latin America.
Posted: 2/20/2024
David S. Boyer, MD; and Marion R. Munk, MD, PhD
David S. Boyer, MD, and Marion R. Munk, MD, PhD, discuss pivotal findings from the LIGHTSITE III clinical trial in patients with dry age-related macular degeneration (AMD). Dr. Boyer underscores the potential of this innovative treatment to deliver meaningful clinical benefits, emphasizing its favorable safety profile. Dr. Munk offers a comprehensive review of the study design and parameters, providing valuable context and interpretation of the trial’s outcomes. Valeda® Light Delivery System is FDA-Authorized, CE-Marked, UKCA-Marked, and commercially available in select countries across Latin America.
Posted: 2/20/2024
About LumiThera
Visit Us Online: lumithera.com
Follow LumiThera
© 2025 LumiThera, Inc. www.lumithera.com
MKT-0039 REV A
Valeda is CE Marked in the EU.
FDA-Authorized
.00_05_13_24.Still001_1746024185.png?auto=compress,format&w=180)